U.S. Investment in Research: Assuring Domestic and Global Dividends
March 20, 2007
Health diplomacy; global public health; medical and scientific advances; health, science and research policies; personalized medicine; and public/private partnerships were among topics discussed at the 2007 Research!America National Forum " U.S. Investment in Research: Assuring Domestic and Global Dividends."
Nearly 200 people-including industry leaders, heads of federal agencies and other stakeholders in research and health-attended the March 20 event at the National Press Club, which was covered by Voice of America. Read the transcript.
|From left, Martin Mackay, PhD; Elias A. Zerhouni, MD; Carolyn M. Clancy, MD; George H. Atkinson, PhD; David Gergen; Susan Dentzer; Freda Lewis-Hall, MD; Julie L. Gerberding, MD, MPH; Christopher A. Viehbacher; Father Thomas G. Streit, CSC, PhD|
Moderator, David Gergen, editor-at-large, U.S. News & World Report and former White House adviser
"Our powers of research can be shared around the world, and health diplomacy is one of many diplomatic tools of soft power available to the U.S."
George H. Atkinson, PhD, science and technology adviser to the Secretary of State
"The United States must define itself as a champion of science, not just as a leader of science."
Carolyn M. Clancy, MD, director, Agency for Healthcare Research and Quality
"Imagine individualized treatment: the right care, for the right person at the right time, every time."
Susan Dentzer, health correspondent, "The NewsHour with Jim Lehrer" on PBS
"The American public is for biomedical research because they know instinctively that it pays off."
Julie Louise Gerberding, MD, MPH, director, Centers for Disease Control and Prevention
"At the CDC we see a world that has some pretty big problems, and these problems affect the promise research brings."
Freda Lewis-Hall, MD, senior vice president, U.S. Pharmaceuticals Medical Affairs, Bristol-Myers Squibb
"I'm in awe of what research has won us in 30 years."
Martin Mackay, PhD, vice president, Pfizer Global Research & Development, senior vice president, Worldwide Development
"More collaboration is being undertaken at Pfizer, to the great benefit of all."
Father Thomas G. Streit, CSC, PhD, director, Haiti Program, Center for Global Health and Infectious Diseases, University of Notre Dame, and Paul G. Rogers Society for Global Health Research Ambassador
"Working in global public health allows young people to express their national idealism and technical savvy."
Christopher A. Viehbacher, president, U.S. Pharmaceuticals, GlaxoSmithKline
"Through research, the United States can have a very positive impact on diplomacy."
Elias A. Zerhouni, MD, director, National Institutes of Health
"This century is going to be science driven. The 20th century saw the discovery of the hardware of life, and the 21st century will be about understanding life's software."
Read the transcripts from the National Forum keynote presentation and panel session, and download a summary of our 2007 National Forum and Advocacy Awards Gala.